Author:
Lohani Kush R.,Hoskin Tanya L.,Day Courtney N.,Yasir Saba,Boughey Judy C.,Degnim Amy C.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. WHO Classification of Tumours Editorial Board. Breast Tumors. International Agency for Research on Cancer, Lyon, France, 2019. (WHO classification of tumors series, 5th ed, vol. 2, p 104). http://publications.iarc.fr/581
2. Ciriello G, Gatza ML, Beck AH, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163:506–19.
3. Lohani KR, Hoskin TL, Day CN, et al. Lobular-like features and outcomes of mixed invasive ductolobular breast cancer (MIDLC): insights from 54,403 stage I-III MIDLC patients. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14455-7.
4. Nasrazadani A, Li Y, Fang Y, et al. Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinoma. Br J Cancer. 2023;128:1030–9.
5. Sinn HP, Kreipe H. A brief overview of the WHO classification of breast tumors. 4th ed. Focusing on issues and updates from the 3rd edition. Breast Care Basel. 2013;8:149–54.